What is the ticker symbol for Mirati Therapeutics?

Mirati Therapeutics trades under the ticker MRTX on NASDAQ.

What sector does Mirati Therapeutics operate in?

Mirati Therapeutics is classified in the Healthcare sector (Biotechnology industry).

How can PortView help analyze MRTX in a portfolio?

PortView shows MRTX's weight in your portfolio, its contribution to return and risk, sector exposure, indirect exposure through ETFs you own, and correlation with your other holdings.

Mirati Therapeutics (MRTX) Stock Analysis

NASDAQHealthcareBiotechnology

$58.70-0.17%

1-year price historyRange $27.80 – $62.38

52-week range$58.70

$27.30$64.41

What Mirati Therapeutics does

Mirati Therapeutics, Inc. is a U.S.-based biotechnology firm operating at the clinical stage, committed to identifying and developing treatments that target the genetic and immunological factors driving cancer progression. Its pipeline features MRTX849, a KRAS G12C inhibitor currently undergoing Phase 1/2 clinical trials for a range of malignancies, including non-small cell lung, colorectal, and pancreatic cancers. Additionally, the company is advancing Sitravatinib, an investigational broad-spectrum kinase inhibitor, which has reached Phase 3 clinical trials specifically for non-small cell lung cancer. Mirati also has a KRAS G12D inhibitor program in its preclinical development phase. The company has forged a collaboration and licensing agreement with BeiGene, Ltd. for the development, manufacturing, and commercialization of sitravatinib. Established in 1995, Mirati Therapeutics, Inc. maintains its headquarters in San Diego, California.

Key metrics

Market cap

$4.12B

P/E (TTM)

-4.82

EPS (TTM)

$-12.18

Beta

0.77

Dividend yield

0.00%

Revenue / share

$0.22

50-day avg

$57.69

200-day avg

$45.48

52-week high

$64.41

52-week low

$27.30

CEO

Charles M. Baum

ETFs linked to MRTX

Broad-market and Healthcare sector ETFs an investor holding Mirati Therapeutics is often also exposed to. Open an ETF page to see its actual top holdings.

SPY — SPDR S&P 500 ETF Trust VOO — Vanguard S&P 500 ETF QQQ — Invesco QQQ Trust VTI — Vanguard Total Stock Market ETF

PortView Portfolio Insights

PortView analyzes how MRTX fits your actual portfolio — position weight, portfolio concentration, unrealized gain/loss, contribution to return, sector exposure, indirect exposure through the ETFs you hold, and correlation with your other holdings. Connect a portfolio to see your personalized figures; PortView never shows another user's private holdings.

Analyze MRTX in PortView →

Similar companies

JNJ — Johnson &LLY — Eli Lilly A — Agilent Technologies ABBV — AbbVie Inc.ABT — Abbott Laboratories ALNY — Alnylam Pharmaceuticals

Frequently asked questions

What is the ticker symbol for Mirati Therapeutics?: Mirati Therapeutics trades under the ticker MRTX on NASDAQ.
Which exchange is MRTX listed on?: MRTX is listed on NASDAQ.
What sector does Mirati Therapeutics operate in?: Mirati Therapeutics is classified in the Healthcare sector (Biotechnology industry).
How can PortView help analyze MRTX in a portfolio?: PortView shows MRTX's weight in your portfolio, its contribution to return and risk, sector exposure, indirect exposure through ETFs you own, and correlation with your other holdings.

The information provided by PortView is for informational and educational purposes only and does not constitute investment advice. Market data may be delayed. Past performance does not guarantee future results.